Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saakshi Khattri

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
JAMA|May 21, 2009
Treadmill exercise or resistance training in patients with peripheral arterial diseaseSaakshi Khattri
JAAD Case Reports|December 17, 2021
Apremilast as a treatment for morphea: A case seriesMerav Koschitzky, Saakshi Khattri
Annals of Internal Medicine|October 8, 2008
Did prescription bias affect outcomes in a study of the relative effectiveness of osteoporosis drugs?Abhimanyu Beri, Saakshi Khattri
Archives of Dermatological Research|February 14, 2025
Jak inhibitor intraclass switch in Alopecia Areata patients: a retrospective review of cases at an academic centerIsabel Silva, Saakshi Khattri
Bulletin of the NYU Hospital for Joint Diseases|August 16, 2012
Primary Sjogren's syndrome and autoimmune cytopenias: a relation often overlookedSaakshi Khattri, Peter Barland
Arthritis and Rheumatism|August 1, 2008
Tendon rupture and statin therapy: is there a link? Comment on the article by Marie et alAbhimanyu Beri, Saakshi Khattri
Journal of Drugs in Dermatology : JDD|June 3, 2026
Dual Therapy for Atopic Dermatitis: Lebrikizumab and JAK inhibitors used in Tandem for Treatment-Resistant CasesAlexandra R Nigro, Saakshi Khattri
Archives of Dermatological Research|May 25, 2024
Low rates of vaccination among atopic dermatitis, alopecia areata, psoriasis, and psoriatic arthritis patients on biologicsM Grace Hren, Saakshi Khattri
Journal of the American Academy of Dermatology|December 10, 2023
Use of systemic Janus kinase inhibitors for dermatologic indications in the elderly: A retrospective study of 67 casesM Grace Hren, Saakshi Khattri
Journal of Cutaneous Medicine and Surgery|January 31, 2025
Combining TNF-α Inhibitors with IL-4, IL-17, IL-23, or JAK Inhibitors in Patients with Multiple, Severe Dermatologic Conditions and/or Gastrointestinal or Rheumatologic DiseaseM Grace Hren, Saakshi Khattri
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
JAMA|May 21, 2009
Treadmill exercise or resistance training in patients with peripheral arterial diseaseSaakshi Khattri
JAAD Case Reports|December 17, 2021
Apremilast as a treatment for morphea: A case seriesMerav Koschitzky, Saakshi Khattri
Annals of Internal Medicine|October 8, 2008
Did prescription bias affect outcomes in a study of the relative effectiveness of osteoporosis drugs?Abhimanyu Beri, Saakshi Khattri
Archives of Dermatological Research|February 14, 2025
Jak inhibitor intraclass switch in Alopecia Areata patients: a retrospective review of cases at an academic centerIsabel Silva, Saakshi Khattri
Bulletin of the NYU Hospital for Joint Diseases|August 16, 2012
Primary Sjogren's syndrome and autoimmune cytopenias: a relation often overlookedSaakshi Khattri, Peter Barland
Arthritis and Rheumatism|August 1, 2008
Tendon rupture and statin therapy: is there a link? Comment on the article by Marie et alAbhimanyu Beri, Saakshi Khattri
Journal of Drugs in Dermatology : JDD|June 3, 2026
Dual Therapy for Atopic Dermatitis: Lebrikizumab and JAK inhibitors used in Tandem for Treatment-Resistant CasesAlexandra R Nigro, Saakshi Khattri
Archives of Dermatological Research|May 25, 2024
Low rates of vaccination among atopic dermatitis, alopecia areata, psoriasis, and psoriatic arthritis patients on biologicsM Grace Hren, Saakshi Khattri
Journal of the American Academy of Dermatology|December 10, 2023
Use of systemic Janus kinase inhibitors for dermatologic indications in the elderly: A retrospective study of 67 casesM Grace Hren, Saakshi Khattri
Journal of Cutaneous Medicine and Surgery|January 31, 2025
Combining TNF-α Inhibitors with IL-4, IL-17, IL-23, or JAK Inhibitors in Patients with Multiple, Severe Dermatologic Conditions and/or Gastrointestinal or Rheumatologic DiseaseM Grace Hren, Saakshi Khattri
Pageof 8